SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.

SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.

SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase and a nuclease that restricts HIV-1 in noncycling cells. Germ-line mutations in SAMHD1 have been described in patients with Aicardi-Goutières syndrome (AGS), a congenital autoimmune disease. In a previous longitudinal whole genome sequenci...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Clifford, R, Louis, T, Robbe, P, Ackroyd, S, Burns, A, Timbs, A, Wright Colopy, G, Dreau, H, Sigaux, F, Judde, J, Rotger, M, Telenti, A, Lin, Y, Pasero, P, Maelfait, J, Titsias, M, Cohen, DR, Henderson, S, Ross, M, Bentley, D, Hillmen, P, Pettitt, A, Rehwinkel, J, Knight, S, Taylor, J
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	American Society of Hematology 2014

Gelijkaardige items

SAMHD1, A Putative Tumour Suppressor, Is Recurrently Mutated in Chronic Lymphocytic Leukaemia, and Is Associated with Poor Risk Features
door: Clifford, R, et al.
Gepubliceerd in: (2012)

Restriction by SAMHD1 limits cGAS/STING-dependent innate and adaptive immune responses to HIV-1
door: Maelfait, J, et al.
Gepubliceerd in: (2016)

SAMHD1-dependent retroviral control and escape in mice.
door: Rehwinkel, J, et al.
Gepubliceerd in: (2013)

SAMHD1-dependent retroviral control and escape in mice
door: Rehwinkel, J, et al.
Gepubliceerd in: (2013)

A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis
door: Wing, P, et al.
Gepubliceerd in: (2019)

Characterisation of SAMHD1's ancestral function
door: Davenne, T
Gepubliceerd in: (2018)

A G1‐like state allows HIV‐1 to bypass SAMHD1 restriction in macrophages
door: Mlcochova, P, et al.
Gepubliceerd in: (2017)

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.
door: Knight, S, et al.
Gepubliceerd in: (2012)

Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.
door: Knight, S, et al.
Gepubliceerd in: (2012)

Clinical‐grade validation of whole genome sequencing reveals robust detection of low‐frequency variants and copy number alterations in CLL
door: Klintman, J, et al.
Gepubliceerd in: (2018)

RECONsidering sensing of cyclic dinucleotides
door: Maelfait, J, et al.
Gepubliceerd in: (2017)

The light chain IgLV3-21 defines a new poor prognostic subgroup in chronic lymphocytic leukemia: Results of a multicenter study
door: Stamatopoulos, B, et al.
Gepubliceerd in: (2018)

Investigating SAMHD1 restriction of HIV-1 in stem cell-derived macrophages
door: Warner, D
Gepubliceerd in: (2020)

Keeping your armour intact: how HIV-1 evades detection by the innate immune system: HIV-1 capsid controls detection of reverse transcription products by the cytosolic DNA sensor cGAS.
door: Maelfait, J, et al.
Gepubliceerd in: (2014)

Nucleic acid sensors and programmed cell death
door: Maelfait, J, et al.
Gepubliceerd in: (2019)

Keeping your armour intact: How HIV-1 evades detection by the innate immune system: HIV-1 capsid controls detection of reverse transcription products by the cytosolic DNA sensor cGAS Prospects and Overviews J. Maelfait et al.
door: Maelfait, J, et al.
Gepubliceerd in: (2014)

Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns.
door: Schuh, A, et al.
Gepubliceerd in: (2012)

A comparison of the efficacy and safety of oral and intravenous fludarabine in chronic lymphocytic leukemia in the LRF CLL4 trial.
door: Dearden, C, et al.
Gepubliceerd in: (2011)

Screening for clinically significant non-deletional alpha thalassaemia mutations by pyrosequencing.
door: Haywood, A, et al.
Gepubliceerd in: (2010)

Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia
door: Quek, L, et al.
Gepubliceerd in: (2016)

Sensing of viral and endogenous RNA by ZBP1/DAI induces necroptosis
door: Maelfait, J, et al.
Gepubliceerd in: (2017)

Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration.
door: Hale, G, et al.
Gepubliceerd in: (2004)

State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia.
door: Clifford, R, et al.
Gepubliceerd in: (2012)

Viruses transfer the antiviral second messenger cGAMP between cells
door: Bridgeman, A, et al.
Gepubliceerd in: (2015)

Multiplex ligation-dependent probe amplification identification of 17 different beta-globin gene deletions (including four novel mutations) in the UK population.
door: Gallienne, A, et al.
Gepubliceerd in: (2009)

Myeloid pre-leukemia and leukemia of Down syndrome
door: Cruz Hernandez, D, et al.
Gepubliceerd in: (2020)

A Case of T-Cell Acute Lymphoblastic Leukemia after Treatment of Acute Promyelocytic Leukemia
door: Bee, P.C., et al.
Gepubliceerd in: (2004)

Identification of Novel Recurrent Copy Number Variations and Regions of Copy-Neutral Loss of Heterozygosity by High Resolution Genomic Array in Pre-Treatment and Relapsed B-CLL.
door: Knight, S, et al.
Gepubliceerd in: (2009)

Acute leukemias in children with Down syndrome.
door: Zwaan, M, et al.
Gepubliceerd in: (2008)

Regulation of the stem cell leukemia (SCL) gene: a tale of two fishes.
door: Barton, L, et al.
Gepubliceerd in: (2001)

Leukemia /
door: 454928 Bozzone, Donna M.
Gepubliceerd in: (2009)

Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial.
door: Pettitt, A, et al.
Gepubliceerd in: (2012)

Co-Existence of LMPP-Like and GMP-Like Leukemia Stem Cells In Acute Myeloid Leukemia
door: Goardon, N, et al.
Gepubliceerd in: (2010)

Co Existence of LMPP Like and GMP Like Leukemia Stem Cells In Acute Myeloid Leukemia
door: Goardon, N, et al.
Gepubliceerd in: (2010)

Co Existence of LMPP Like and GMP Like Leukemia Stem Cells In Acute Myeloid Leukemia
door: Goardon, N, et al.
Gepubliceerd in: (2010)

Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.
door: Guièze, R, et al.
Gepubliceerd in: (2015)

Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.
door: Goardon, N, et al.
Gepubliceerd in: (2011)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
door: Reinhardt, K, et al.
Gepubliceerd in: (2010)

GATA1 Mutation In Transient Leukemia (TL) and Myeloid Leukemia of Down Syndrome
door: Reinhardt, K, et al.
Gepubliceerd in: (2010)

Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV(mut) and IgHV(unmut) subgroups
door: Burns, A, et al.
Gepubliceerd in: (2017)